Trial intelligence / Profile preview

Axillary perineural dexmedetomidine for hemodynamic stability and postoperative pain in upper extremity orthopedic surgery

IRCT2017050833860N1Phase 3Completed

Sponsor
Kashan University of Medical Sciences
Start
Jul 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of dexmedetomidine in Forearm Fracture, sponsored by Kashan University of Medical Sciences. Primary endpoints: Intraoperative hemodynamic changes and Postoperative pain. Started Jul 2017; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

Forearm Fracture

Beyond the preview

Go deeper on IRCT2017050833860N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2017050833860N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call